Today Ra Pharmaceuticals CEO Doug Treco will make a presentation at a conference in Las Vegas that will cap off the Cambridge, MA-based company’s weeklong unveiling. On May 16, Ra announced it had closed an $8.6 million tranche of its $27 ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ra Pharmaceuticals today announced it is pursuing hereditary angioedema (HAE) as a lead program, leveraging the Company’s proprietary Cyclomimetic™ drug discovery and development platform. HAE is a rare, but serious ...

Did you know that your risk of having a heart attack doubles in the ten years following your RA diagnosis? This sobering bit of information from the American College Of Rheumatology started my mind running. I wanted to know why we have a higher risk of ...

May 24, 2012 (Honolulu, Hawaii) -- Young patients with rheumatoid arthritis (RA) may feel better after practicing yoga for just six weeks, a new study shows. Researchers reported their findings here last week at the American Pain Society's annual meeting.

Quiet Ra Pharmaceuticals of Cambridge said today that it has closed $8.6M in a second tranche of a $27 million Series A round and will pursue hereditary angioedema (HAE) as the lead program for its Cyclomimetic drug discovery and development ...

The researchers reviewed charts of 151 patients with RA who had been seen by 3 rheumatologists. Overall, they found that patients with RA were evaluated by a rheumatologist at a mean of approximately 11 months after the onset of symptoms of ...

A new study led by researchers at Hospital for Special Surgery identifies the mechanism by which a cell signaling pathway contributes to the development of rheumatoid arthritis (RA). In addition, the study provides evidence that drugs under ...

Srinagar, May 21: Jammu and Kashmir Himayat- ul-Islam on Monday underscored the need for following the footsteps of Hazrat Abu Bakre Siddiq (RA) in order to remain united and overcome the so-called sectarian issues created by vested interests.

RA Sushi will host its eighth annual “Nicky’s Week” fundraiser Sunday, May 27, through Saturday, June 2, to benefit St. Jude Children’s Research Hospital, one of the world’s premier centers for research and treatment of pediatric cancer and ...

Cambridge, MA-based Ra Pharmaceuticals is stealth no more. Two years after it snagged an initial $10 million in venture cash, Ra has hauled in a second tranche of $8.6 million and picked its disease target: hereditary angioedema, a rare and ...